The distribution and temporal and clinical features of amino acid substitutions of the core protein of hepatitis B (HB) virus were analyzed, using at least 2 sequential samples from 27 patients. Six patients seroconverted from HBe antigen (HBeAg) -positive to anti-HBe -positive (3 went into remission), and 21 were continuously anti-HBe positive with progressive hepatitis. Precore mutations, which terminate HBeAg translation, all appeared by the second sample. Most core mutations occurred between the first and second samples; significantly fewer occurred after the second. In seroconverters who went into remission, mutations occurred in the T helper epitope from aa 50 to 69 (P Å .00045); for anti-HBe -positive patients with ongoing disease, mutations occurred in B cell epitopes (P Å .0007 for aa 74 -83). An ineffective anti-HBc B cell response accounts for ongoing disease and selection of mutations after seroconversion. In those who remit, mutations in the major T helper epitope allow immune escape, thus minimizing immune-mediated hepatitis.
The pathogenesis of infection with hepatitis B virus (HBV)
The fundamental questions of whether mutations in B and Th cell epitopes are a cause or an effect of disease and why is complex. The reasons for the variable outcome of infection, patients who have this presumed ''immune escape'' have ongoranging from acute hepatitis to hepatocellular carcinoma, are ing disease (as disease is due to immune attack) are entirely largely unexplained. A good example is that either progression unresolved. Although viruses with mutant HBc sequences that of disease or clinical remission can occur after seroconversion are antagonistic for HLA-A2 class 1 -restricted cytotoxic T to anti-HBe. Anti-HBe -positive progressive hepatitis is particlymphocyte (CTL) epitopes have been described rarely in ularly common among Mediterranean peoples, indicating that chronic carriers, suggesting a potential mechanism of viral perthere may be a host genetic factor. In fact, this has become the sistence, there are no consistent mutations in known HLAcommonest presenting clinical picture of chronic hepatitis in A2 class 1 -restricted HBc epitopes from patients with active Mediterranean countries (unpublished observations). Although disease [8 -11] . The explanation for this phenomenon is probaliver injury is believed to be due to immune responses against bly that in chronic HBV infection, the CTL response is too HBV-infected hepatocytes, the target specificity of the response weak to exert selection pressure, whereas in acute HBV infecand the effector cells involved are not fully characterized. In tion, the emergence of mutants is prevented by the polyclonality addition, there remains some debate about a potential direct and multispecificity of the response [12] . In fact, this difference cytopathic effect of the virus.
in CTL responses is thought to be fundamental to the outcome Some progress has been made recently in teasing out the of infection. relationship between host and viral factors in this process:
We and others have shown previously that HBc mutations There are associations between virus clearance during acute are found rarely in HBe antigen (HBeAg) -positive patients infection and the presence of specific HLA class II alleles [1] , with severe disease, indicating that disease per se is not suffiand mutations in hepatitis B core (HBc) protein are related to cient for immune selection. The near identity of the sequences disease progression [2 -7] . In cross-sectional studies, representallowed a consensus sequence to be derived. Mutations away ing accumulated variability over time and many different clinifrom this consensus are most frequent in anti-HBe -positive cal situations, these mutations are found significantly more persons with severe chronic hepatitis [5] and those with fulmifrequently in known HBc T helper (Th) cell and B cell epitopes nant hepatitis [3, 4, 7] . In keeping with the presumed mecha-[5] than in interepitope regions, implying that they are a result nism of immune selection, anti-HBe -positive persons without of immune selection.
active disease have very few mutations away from this consensus [5] . There is also a clear association with the presence of HBeAg nonproducer strains that have precore mutations [13 -16] , the commonest of which is a G-to-A change at nt 1896, A 1896 , resulting in a stop codon and frequent HBc mutations.
Persons with chronic and severe anti-HBe -positive hepatitis cases typically have multiple flare-ups of hepatitis with corresponding peaks of aminotransferases. These have been shown to correlate with increased T cell proliferation responses to HBc and HBeAg and reappearance of IgM anti-HBc [17] . One hypothesis, therefore, is that this heightened immune response may put selection pressure on these epitopes, leading to selection of a new mutant with each transaminase peak, which in turn results in a fresh bout of hepatitis. Here, sequential core sequences from 27 patients have been analyzed to describe the number, distribution, and timing of amino acid (aa) substitutions in core protein and to correlate them with known HBc B and Th epitopes.
Patients and Methods
Patients. All study subjects lived in Italy or Greece and were followed at regular intervals. Multiple serum samples were available from each patient. Nearly all samples tested positive for HBV DNA by dot-blot hybridization assay, which has a cut-off of Ç2 pg/mL. For patients H20 (figure 1) and H24 (figure 2), DNA levels õ2 pg/mL correlated with normal levels of alanine aminotransferase. All other samples tested were positive by hybridization. None of the patients had undergone interferon therapy. Patients with antibodies to human immunodeficiency virus or with hepatitis delta virus infection were excluded from study.
Six HBeAg-to-anti-HBe seroconverters and 21 continuously anti-HBe-positive patients with ongoing hepatitis were selected for study. In the first group, 3 patients went on to active disease, and 3 went into clinical remission and lost DNA (as determined by hybridization) after seroconversion. For the second group, patients were already anti-HBe positive when they presented to the clinic, so the first samples studied were the ones from the first visit; therefore, it was unknown when seroconversion to anti-HBe had occurred. These 2 groups were chosen because the immune mechanisms of disease may be different. The timing of samples is given in figures 1 and 2.
To time more precisely the appearance of HBc mutations that emerged between the first and last samples in the continuously anti-HBe positive group, intermediate samples were collected, and the HBc core gene was sequenced in a focussed manner (i.e., the complete gene was not characterized). Samples were sequenced in order of collection; no subsequent samples in the series were analyzed once the appearance of all the mutations detected in the final sample (compared with the first) had been timed. An additional analysis was done on a subset of continuously anti-HBepositive patients to address the issue of whether transient mutations sometimes appear that are then cleared by the immune response during a flare of hepatitis and so would not be observed in the final sample. For this purpose, the complete HBc sequence was characterized from 4 or 5 sequential samples from each of 3 patients. Clinical details are given in figures 1 and 2, and representative clinical profiles for patients are shown in figure 1 .
Polymerase chain reaction (PCR) and sequencing. The number of sera analyzed by PCR sequencing is given in figures 1 and 2. PCR was done on the extracted nucleic acid from 25 mL of digested sera. Digestions were performed with proteinase K, using GGGAGGAGATT, and C2N, 5-CCCGTAAAGTTCCCGACCTT.
Clinical correlates and distribution of mutations in HBe -
Second-round (nested) primers were C3, 5-CGGGATCCCTTTto -anti-HBe seroconverters. Figure 1 shows so the relative horizontal distances in the figures do not add
The rate of mutation within an epitope was compared with the up to the full length of the gene. in the common Th epitope from aa 50 to 69 was verging on the level of significance (OR, 0.55; 95% CI, 0.28 -1.08; P Å .06). Figure 3 shows that even though multiple flares of hepatiResults tis occurred in these patients, extra substitutions seldom emerged before or after each peak. Relationship between precore and core mutations. A Last, the entire precore/core region of 5 sequential serum strong temporal association was noted between selection of samples from patients H21 and H33 and 4 sequential samples precore mutants that do not allow translation of HBeAg (e.g., from patient H35 were sequenced to search for transient substi-A 1896 ) and HBc aa substitution (figures 1 -3) . In continuously tutions: None were found. anti-HBe -positive subjects (patients H21, H28, H33, H38, Discussion A10, A12, A20, A21, and A23) for whom a precore mutant was already present in the first available sample, few HBc aa HBeAg -to -anti-HBe seroconversion is associated with contemporaneous selection of mutations in the precore region substitutions appeared between the first and last samples (range, / 9d27$$my06 03-24-97 13:55:21 jinfal UC: J Infect that abrogate HBeAg synthesis (e.g., A 1896 ) and substitutions in strains that are present at õ5% (the limit of our direct PCR sequencing sensitivity) of the population. This was not assessed here, as it would be logistically very difficult to study enough which shares large stretches of protein sequence, with the result samples to achieve statistical significance. that loss of HBeAg leads to an enhanced immune response, These results also give us clues for the first time to the and thus selection pressure, against HBc. Most of the observed immune effectors that are associated with chronic active hepatisubstitutions occurred between the first and second samples tis, subsequently forcing virus escape. In earlier cross-sectional (table 3) . Substitutions do continue to accumulate but to a much analyses, in which comparisons were made with a consensus lesser degree between the second and final samples. However, sequence, anti-HBe -positive subjects with active hepatitis had we have not been able to show any regular temporal association greater numbers of mutations in the commonly recognized Th with the aminotransferase peaks and, thus, with flare-ups of epitope (aa 50 -69) and in two of three of the anti-HBc/e B hepatitis (figure 3).
cell epitopes. In contrast, in the sequential samples analyzed It has not been resolved whether HBc protein substitutions here, in which sequences were compared with their predecescause severe disease, possibly by inducing a fresh immune sors, mutations in patients who went into remission appeared response, or whether they merely represent immune escape.
to occur in the Th epitope, and mutations in patients with We believe the former is unlikely for three reasons. First, if a ongoing disease occurred in B cell epitopes. There may be substitution appears that leads to a fresh immune attack, the some pressure on the common Th epitope since the number of mutations in this area was verging on significance. In the crossprediction is that this virus population would be cleared. How- sectional analysis, the number of Th mutations represented
